Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Will engineered T cells expressing CD20 scFv eradicate Melanoma?

Literature DB >> 21455210

Will engineered T cells expressing CD20 scFv eradicate Melanoma?

Rajasekharan Somasundaram¹, Jessie Villanueva, Meenhard Herlyn.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 21455210 PMCID： PMC3070110 DOI： 10.1038/mt.2011.46

Source DB: PubMed Journal: Mol Ther ISSN： 1525-0016 Impact factor: 11.454

× No keyword cloud information.

20 in total

Review 1. Melanoma.

Authors: Arlo J Miller; Martin C Mihm
Journal: N Engl J Med Date: 2006-07-06 Impact factor: 91.245

2. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.

Authors: Cor H J Lamers; Stefan Sleijfer; Arnold G Vulto; Wim H J Kruit; Mike Kliffen; Reno Debets; Jan W Gratama; Gerrit Stoter; Egbert Oosterwijk
Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544

3. Eradication of melanomas by targeted elimination of a minor subset of tumor cells.

Authors: Patrick Schmidt; Caroline Kopecky; Andreas Hombach; Paola Zigrino; Cornelia Mauch; Hinrich Abken
Journal: Proc Natl Acad Sci U S A Date: 2011-01-31 Impact factor: 11.205

4. Looking ahead in cancer stem cell research.

Authors: John E Dick
Journal: Nat Biotechnol Date: 2009-01 Impact factor: 54.908

5. A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.

Authors: Michael H Kershaw; Jennifer A Westwood; Linda L Parker; Gang Wang; Zelig Eshhar; Sharon A Mavroukakis; Donald E White; John R Wunderlich; Silvana Canevari; Linda Rogers-Freezer; Clara C Chen; James C Yang; Steven A Rosenberg; Patrick Hwu
Journal: Clin Cancer Res Date: 2006-10-15 Impact factor: 12.531

Review 6. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.

Authors: Ali R Jazirehi; Benjamin Bonavida
Journal: Oncogene Date: 2005-03-24 Impact factor: 9.867

7. A tumorigenic subpopulation with stem cell properties in melanomas.

Authors: Dong Fang; Thiennga K Nguyen; Kim Leishear; Rena Finko; Angela N Kulp; Susan Hotz; Patricia A Van Belle; Xiaowei Xu; David E Elder; Meenhard Herlyn
Journal: Cancer Res Date: 2005-10-15 Impact factor: 12.701

8. Identification of cells initiating human melanomas.

Authors: Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal: Nature Date: 2008-01-17 Impact factor: 49.962

9. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.

Authors: P Chattopadhyay; S V Kaveri; N Byars; J Starkey; S Ferrone; S Raychaudhuri
Journal: Cancer Res Date: 1991-11-15 Impact factor: 12.701